Hiroyuki Nojima1, Christopher M Freeman1, Rebecca M Schuster1, Lukasz Japtok2, Burkhard Kleuser2, Michael J Edwards1, Erich Gulbins3, Alex B Lentsch4. 1. Department of Surgery, University of Cincinnati, College of Medicine, Cincinnati, OH 45267, USA. 2. Institute of Nutritional Science, University of Potsdam, Arthur-Scheunert Allee 114-116, 14558 Nuthetal, Germany. 3. Department of Surgery, University of Cincinnati, College of Medicine, Cincinnati, OH 45267, USA; Department of Molecular Biology, University of Duisburg-Essen, Hufelandstrasse 55, 45122 Essen, Germany. 4. Department of Surgery, University of Cincinnati, College of Medicine, Cincinnati, OH 45267, USA. Electronic address: alex.lentsch@uc.edu.
Abstract
BACKGROUND & AIMS: Exosomes are small membrane vesicles involved in intercellular communication. Hepatocytes are known to release exosomes, but little is known about their biological function. We sought to determine if exosomes derived from hepatocytes contribute to liver repair and regeneration after injury. METHODS: Exosomes derived from primary murine hepatocytes were isolated and characterized biochemically and biophysically. Using cultures of primary hepatocytes, we tested whether hepatocyte exosomes induced proliferation of hepatocytes in vitro. Using models of ischemia/reperfusion injury and partial hepatectomy, we evaluated whether hepatocyte exosomes promote hepatocyte proliferation and liver regeneration in vivo. RESULTS: Hepatocyte exosomes, but not exosomes from other liver cell types, induce dose-dependent hepatocyte proliferation in vitro and in vivo. Mechanistically, hepatocyte exosomes directly fuse with target hepatocytes and transfer neutral ceramidase and sphingosine kinase 2 (SK2) causing increased synthesis of sphingosine-1-phosphate (S1P) within target hepatocytes. Ablation of exosomal SK prevents the proliferative effect of exosomes. After ischemia/reperfusion injury, the number of circulating exosomes with proliferative effects increases. CONCLUSIONS: Our data shows that hepatocyte-derived exosomes deliver the synthetic machinery to form S1P in target hepatocytes resulting in cell proliferation and liver regeneration after ischemia/reperfusion injury or partial hepatectomy. These findings represent a potentially novel new contributing mechanism of liver regeneration and have important implications for new therapeutic approaches to acute and chronic liver disease.
BACKGROUND & AIMS: Exosomes are small membrane vesicles involved in intercellular communication. Hepatocytes are known to release exosomes, but little is known about their biological function. We sought to determine if exosomes derived from hepatocytes contribute to liver repair and regeneration after injury. METHODS: Exosomes derived from primary murine hepatocytes were isolated and characterized biochemically and biophysically. Using cultures of primary hepatocytes, we tested whether hepatocyte exosomes induced proliferation of hepatocytes in vitro. Using models of ischemia/reperfusion injury and partial hepatectomy, we evaluated whether hepatocyte exosomes promote hepatocyte proliferation and liver regeneration in vivo. RESULTS: Hepatocyte exosomes, but not exosomes from other liver cell types, induce dose-dependent hepatocyte proliferation in vitro and in vivo. Mechanistically, hepatocyte exosomes directly fuse with target hepatocytes and transfer neutral ceramidase and sphingosine kinase 2 (SK2) causing increased synthesis of sphingosine-1-phosphate (S1P) within target hepatocytes. Ablation of exosomal SK prevents the proliferative effect of exosomes. After ischemia/reperfusion injury, the number of circulating exosomes with proliferative effects increases. CONCLUSIONS: Our data shows that hepatocyte-derived exosomes deliver the synthetic machinery to form S1P in target hepatocytes resulting in cell proliferation and liver regeneration after ischemia/reperfusion injury or partial hepatectomy. These findings represent a potentially novel new contributing mechanism of liver regeneration and have important implications for new therapeutic approaches to acute and chronic liver disease.
Authors: Vedashree Ramakrishnaiah; Christine Thumann; Isabel Fofana; Francois Habersetzer; Qiuwei Pan; Petra E de Ruiter; Rob Willemsen; Jeroen A A Demmers; Victor Stalin Raj; Guido Jenster; Jaap Kwekkeboom; Hugo W Tilanus; Bart L Haagmans; Thomas F Baumert; Luc J W van der Laan Journal: Proc Natl Acad Sci U S A Date: 2013-07-22 Impact factor: 11.205
Authors: Gregory C Wilson; Satoshi Kuboki; Christopher M Freeman; Hiroyuki Nojima; Rebecca M Schuster; Michael J Edwards; Alex B Lentsch Journal: PLoS One Date: 2015-03-10 Impact factor: 3.240
Authors: Yael Pewzner-Jung; Shaghayegh Tavakoli Tabazavareh; Heike Grassmé; Katrin Anne Becker; Lukasz Japtok; Jörg Steinmann; Tammar Joseph; Stephan Lang; Burkhard Tuemmler; Edward H Schuchman; Alex B Lentsch; Burkhard Kleuser; Michael J Edwards; Anthony H Futerman; Erich Gulbins Journal: EMBO Mol Med Date: 2014-09 Impact factor: 12.137
Authors: Ernest T Chivero; Raghubendra Singh Dagur; Eric S Peeples; Susmita Sil; Ke Liao; Rong Ma; Liang Chen; Channabasavaiah B Gurumurthy; Shilpa Buch; Guoku Hu Journal: Cell Mol Life Sci Date: 2021-04-05 Impact factor: 9.261
Authors: Petra Hirsova; Samar H Ibrahim; Vikas K Verma; Leslie A Morton; Vijay H Shah; Nicholas F LaRusso; Gregory J Gores; Harmeet Malhi Journal: Hepatology Date: 2016-10-20 Impact factor: 17.425
Authors: Nina M Ćulum; Tyler T Cooper; Gillian I Bell; David A Hess; François Lagugné-Labarthet Journal: Anal Bioanal Chem Date: 2021-06-17 Impact factor: 4.142